In modern conditions, the competitiveness of drugs is determined not only by the direction of their action, relevance, but also by the level of quality, quality-price ratio. In creating conditions for the production of competitive solid dosage forms, in particular tablets, a scientifically based selection of high-quality excipients is essential. In the development and improvement of the production of modern solid dosage forms, the leading role is played by high-molecular compounds, which make it possible tocreate drugs with predictable biopharmaceutical and technological parameters. In domestic pharmaceutical production, a new generation of high-molecular auxiliary substances produced by foreign companies is increasingly being introduced
In modern conditions, the competitiveness of drugs is determined not only by the direction of their action, relevance, but also by the level of quality, quality-price ratio. In creating conditions for the production of competitive solid dosage forms, in particular tablets, a scientifically based selection of high-quality excipients is essential. In the development and improvement of the production of modern solid dosage forms, the leading role is played by high-molecular compounds, which make it possible tocreate drugs with predictable biopharmaceutical and technological parameters. In domestic pharmaceutical production, a new generation of high-molecular auxiliary substances produced by foreign companies is increasingly being introduced
| № | Author name | position | Name of organisation |
|---|---|---|---|
| 1 | Azimova N.A. | ! | ! |
| 2 | Maksudova F.K. | ! | ! |
| 3 | Dusmetova Z.R. | ! | ! |
| 4 | Rakhimova G.. | ! | ! |
| 5 | Rakhimova O.. | ! | ! |
| № | Name of reference |
|---|---|
| 1 | 1. Sheskey, PJ, Cook, WG, and Cable, CG, 2017, Handbook of Pharmaceutical Excipients, Pharmaceutical Press, The Royal Phramaceutical Society of Great Britain, p. 138-152; 505-527.2. GK Bolhuis and ZT Chowhan, “Materials for direct compaction,” Pharmaceutical Powder Compaction Technology (ed. Alderborn G, Nyström C), Marcel Dekker, New York, 2013, pages 419-478.3. W. Zebrowska and W. Sawicki, “Excipients,” The applied pharmacy (ed. S. Janicki, A. Fiebig, M. Sznitowska), PZWL, Warsaw 2008, pages 652-693.4. Yu.E. Kirsch, Chemical-pharmaceutical journal, 17(6),7 –1 1 (2014).5. Michoel, A., and Rombaut, P., 2022, Comparative evaluation of co-processed lactose and microcrystalline cellulose with their physical mixtures in the formulation of folic acid tablets, Pharm Dev Technol., 7; 79-87.6. Patent USA 5225206 MKU A 61 K 9/16, 9/54 Sustaned release pranoproten preparation. Fushimi Magurani, et al., no. 192563374. 7. Patent 5492696 USA MKU A01 No. 25/34, 59/20. Control led release microstructures R.P. price, P.E. Schoen, M. Testoff, et al., no. 194563275.8. Mamatha, B., Srilatha, D., Sivanarayani1, CH,Prasanna KD, and Rao, P.V., 2023, CO-Processed Excipients: An Overview, World J Pharm Res., 6(15); 224-2379. A.P. Zuev, N.P. Sadchikova, Tyulyaev, Chemical-pharmaceutical journal. , 37 (11), 29–31 (2022).10.V.M. Lehtola , J.T. Heinamaki , P. Nikupaavo, et al., Drug Dev. and Ind. Pharm. , 21 (12), 1365 –1375 (2012).11. Y. Kane, J. Rambaud, H. Maillols, et al., Drug Dev. and Ind. Pharm. , 20 (6), 1021 –1034 (2018).12. USP-NF, 2018, The United States Pharmacopeia and the National Formulary, USP 41–NF 36, The United States Pharmacopeial Convention, Rockville, USA p.701113.E. A. Hosny, Pharm . Act a Helv., 72 (5), 255 –261 (2021).14. N.H. Shah, J. Lazarus, PR Sheth, S.J. Jarowsky, J. Pharma ceut. Sci. , 6, 611 –613 (2019).15.R.Thribert, S. T. P. Pharma Sci , 2 (11), 123 –128 (2023).16.MR Laura, M.L. Torre, I. Maggi, S.T.P. Pharma Sci , 4 (11), 265–269 (2022).17.G.K. Bolhuis, Eur. J. Pharm. Sci , 2 (5), 63–69 (2022).18.C. R. Chen, Chem. Pharm. Bull., No. 46, 478 –481 (2023).19.TA Miller, P. Yorс, Int. J. Pharm. , 41.1–19 (2024).20.G.K. Bolhuis, A.J. Smallenbroek, and C.F. Lerk, J. Farm. Sci , 70 , 1328 (2021).21. Amol. M., Bhairav, B.A., and Saudager, R.B., 2017, Co-Processed Excipients for Tabletting: Review Artikel, Res J Pharm and Tech., 10(7): 2427-243222. Atul, P., Subrata, K., and Ganga, S., 2022, A review on co-processed excipients: a novel approach in formulation development. IJRAPI., 3; 25-4123. Bansal, AK, and Nachaegari, S, K., 2014,Co processed excipient for solid dosage form. Pharm Technol., 2; 52-64.24. Bin, L. K., Gaurav, A., and Mandal, UK, 2019, A Review on Co-Processed Excipients: Current and Future Trend of Excipient Technology, Int J Pharm Pharm Sci., 11 (1); 1-9.25. Bolhuis, G. K., Veen, B., Wu, Y. S., Zuuraman, K., and Frijlink, H. W., 2019, Compaction mechanism and tablet strength of unlubricated and lubricated silicified microcrystalline cellulose. Eur J Pharm Biopharm 59:133–8.26. Desai, U., Chavan, R., Mhatre, P., and Chinchole, R., 2012, A Review: Coprocessed Excipients, Int J Pharm Sci Rev and Res., 12, (2); 93-10527. Franc, A., Vetchý, D., Vodáčková, P., Kubaľák, R., Jendryková, L., Goněc, R., 2024, Co-processed excipients for direct compression of tablets, Ces. slov. Farm. 67; 175–18128. Galbraith, S.C., Cha, B., Huang, Z., ,Park, S., Liu, H., Meyer, R.F., Flamm, M.H., Hurley, S., Zhang-Plasket, F., and Yoon, S., 2019, Integrated modeling of a continuous direct compression tablet manufacturing process: A production scale case study, Powder Technology, 354; 199–210.29. Gohel, MC, 2022, A review of co-processed directly compressible excipients, J Pharm Pharmaceut Sci., 8 (1); 76-93.30. Gohel, MC, and Jogani, PD, 2019, A review of co-processed directly compressibleexcipients. J Pharm Pharm Sci., 8; 76-93.31. Hauschild, K., and Picker, K. M., 2023, Evaluation of a new co-processed compound based on lactose and maize starch for tablet formulation, AAPS Pharm Sci., 6:1-12.32. Lan, Y., 2008, A New Excipient for Fast Disintegrating Oral Dosage Forms, Pharma Ingredients & Services, BASF33. Nagendrakumar, D., Raju, S.A., Shirsand, S.B., and Para, M.S., 2019, Design of fast dissolving granisetron HCL tablets using novel coprocessed superdisintegrants, J Biosci Technol., 1; 8-14.34. Nofrerias, I., Nardi, A., Suñé-Pou, M., Suñé-Negre, JM, García-Montoya, E., Pérez-Lozano, P., Ticó, JR, and Miñarro, M., 2023 , Comparison between Microcrystalline Celluloses of different grades made by four manufacturers using the SeDeM diagram expert system as a pharmaceutical characterization tool, Powder Technology, 342; 780–78835. Rojas, J., and Kumar, V., 2021, Comparative evaluation of silicified microcrystalline cellulose as a direct compression vehicle, Int J Pharm. 416(1); 120-12836. Satish, KN, and Arvind, KB, 2023, Coprocessed Excipients for Solid Dosage Forms, Pharmaceutical Technology, Januari, 52-6437. Saiga, l. N., Baboota, S., Ahuja, A., and Ali, J., 2022., Microcrystalline Cellulose as a Versatile Excipient in Drug Research,J Young Pharm, 1; 6-1238. Steele, D. F., Tobyn, M., Edge, S., Chen, A., and Staniforth, J. N. 2018., Physicochemical and mechanical evaluation of a novel high density grade of silicified microcrystalline cellulose, Drug Dev. Ind. Pharm., 30; 103–10939. Thulluru, A., Madhavi, C., Nandini, K., Sirisha, S., and Spandana, D., 2019, Co-Processed Excipients: New Era in Pharmaceuticals, Asian J. Res. Pharm. Sci. 9(1): 01-05. |